SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
+3.37%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$277M
AUM Growth
-$11.9M
(-4.1%)
Cap. Flow
-$63.1M
Cap. Flow
% of AUM
-22.78%
Top 10 Holdings %
Top 10 Hldgs %
46.92%
Holding
254
New
37
Increased
27
Reduced
73
Closed
42
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$8.46M |
| 2 |
CELG
Celgene Corp
CELG
|
$3.94M |
| 3 |
United Therapeutics
UTHR
|
$3.32M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$2.76M |
| 5 |
Tenet Healthcare
THC
|
$2.56M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$15.2M |
| 2 |
Abbott
ABT
|
$6.42M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.21M |
| 4 |
Amgen
AMGN
|
$3.49M |
| 5 |
NVIV
InVivo Therapeutics Holdings Corp
NVIV
|
$3.35M |
Sector Composition
| 1 | Healthcare | 87.44% |
| 2 | Consumer Staples | 0.39% |
| 3 | Technology | 0.24% |
| 4 | Industrials | 0.1% |
| 5 | Materials | 0.02% |
